Aller au contenu principal
Profil bibliographique

Kelvin Charambira

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
82Citations signalées
0Affiliations récentes

Les domaines associés

Tuberculosis Research and EpidemiologyDiagnosis and treatment of tuberculosisPneumocystis jirovecii pneumonia detection and treatmentMalaria Research and ControlHIV-related health complications and treatments

Les publications récentes

Accès ouvert 2020 article OpenAlex

Declining Trends in Childhood TB Notifications and Profile of Notified Patients in the City of Harare, Zimbabwe, from 2009 to 2018

Phoebe Nzombe, Srinath Satyanarayana, Hannock M. Tweya, Collins Timire et autres

Globally, childhood tuberculosis (TB among those aged <15 years) is a neglected component of national TB programmes in high TB burden countries. Zimbabwe, a country in southern Africa, is a high burden country for TB, TB-HIV, and drug-resistant TB. In this study, …

fr, Malawi, Zimbabwe (code pays fourni par la source)

9 citations Journal of Tropical Medicine
Accès ouvert 2020 article OpenAlex

Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015

Ronnie Matambo, Kudakwashe Collin Takarinda, Pruthu Thekkur, Charles Sandy et autres

BACKGROUND: Zimbabwe is one of the thirty countries globally with a high burden of multidrug-resistant tuberculosis (TB) or rifampicin-resistant TB (MDR/RR-TB). Since 2010, patients diagnosed with MDR/RR-TB are being treated with 20-24 months of standardized second-line drugs (SLDs). The profile, management and …

Zimbabwe, fr, in (code pays fourni par la source)

22 citations PLoS ONE
Accès ouvert 2019 article OpenAlex

Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey

Collins Timire, John Z. Metcalfe, Joconiah Chirenda, Jerod N. Scholten et autres

OBJECTIVE: To determine the prevalence of resistance to rifampicin alone; rifampicin and isoniazid, and second-line anti-TB drugs among sputum smear-positive tuberculosis patients in Zimbabwe. DESIGN: A health facility-based cross-sectional survey. RESULTS: In total, 1114 (87.6%) new and 158 (12.4%) retreatment TB patients …

Zimbabwe, fr, us, nl (code pays fourni par la source)

21 citations International Journal of Infectious Diseases
Accès ouvert 2019 article OpenAlex

Feasibility and yield of screening for diabetes mellitus among tuberculosis patients in Harare, Zimbabwe

Ronald Thulani Ncube, Sushil Dube, S. M. Machekera, Collins Timire et autres

Setting: A resource-limited urban setting in Zimbabwe with a high burden of tuberculosis (TB) and human immunodeficiency virus (HIV). Objectives: To determine the feasibility and yield of diabetes mellitus (DM) screening among TB patients in primary health care facilities. Design: A descriptive …

Zimbabwe, fr (code pays fourni par la source)

16 citations Public Health Action
Accès ouvert 2016 article OpenAlex

Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert ® MTB/RIF in Zimbabwe

Kelvin Charambira, S. Adè, Anthony David Harries, Ronald Thulani Ncube et autres

SETTING: In Zimbabwe, there are concerns about the management of tuberculosis (TB) patients with rifampicin (RMP) resistance diagnosed using Xpert(®) MTB/RIF. OBJECTIVE: To assess linkages between diagnosis and treatment for these patients in Harare and Manicaland provinces in 2014. DESIGN: A retrospective …

fr, Bénin, gb, Zimbabwe (code pays fourni par la source)

14 citations Public Health Action

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.